Glypican-1 identifies cancer exosomes and detects early pancreatic cancerSónia A. Melo, Raghu Kalluri, Linda B. Luecke et al.|Nature|2015Cited by 2.9k
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trialElizabeth A. Mittendorf, Nadia Harbeck, Hong Zhang et al.|The Lancet|2020Cited by 1.1k
Current Landscape of Immunotherapy in Breast CancerSylvia Adams, Elizabeth A. Mittendorf, Margaret E. Gatti‐Mays et al.|JAMA Oncology|2019Cited by 409
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancerAnita K. Mehta, Jennifer L. Guerriero, Emily Cheney et al.|Nature Cancer|2020Cited by 271
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancerDavid B. Page, Sylvia Adams, Harry D. Bear et al.|npj Breast Cancer|2019Cited by 86